It was a great pleasure to meet with Anthony Tang to discuss the RAFT-AF trial results investigating the safety and efficacy of catheter ablation-based rhythm control compared with rate control for the treatment of patients with atrial fibrillation and heart failure, presented at ACC 2021.
- What were the aims and design of the RAFT study? (0:19)
- What were the key inclusion criteria of the study? (0:44)
- Could you tell us a little about the study findings in terms of primary and secondary outcomes, and the reasons for early termination of the study? (1:44)
- How did these findings compare with other studies comparing rhythm-control and rate-control strategies among patients with atrial fibrillation and heart failure? (5:58)
- What are the implications of these findings for the management of patients with atrial fibrillation and heart failure, and what future studies are needed? (7:50)
Speaker disclosures: Anthony Tang has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media.
Filmed during a remote video call with Professor Anthony Tang as a highlight of ACC 2021, May 2021.
Share this Video
Related Videos In Heart Failure
Justin Ezekowitz, ACC 2022: SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure
The SODIUM-HF trial tested whether or not a reduction in dietary sodium reduces the incidence of heart failure. touchCARDIO speaks with Prof. Justin Ezekowitz (University of Alberta, Edmonton, Canada) to discuss his presentation on the SODIUM-HF study on the effect of sodium restriction on mortality and morbidity in patients with heart failure. The presentation entitled […]
Mikhail Kosiborod, ACC 2022: Results From the EMPULSE Trial: Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized For Acute Heart Failure
The EMPULSE trial showed the effects of empagliflozin on symptoms, physical limitations and quality of life in patients hospitalized for acute heart failure. touchCARDIO speaks with Prof. Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, Kansas City, MO) to discuss his presentation on the EMPULSE trial and the impact of SGLT-2 inhibitors and where they […]
Mark Loeb, ACC 2022: IVVE: Randomized Controlled Trial of Influenza Vaccine in Patients with Heart Failure to Reduce Adverse Vascular Events
The IVVE study is a randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events. It was delightful to speak with Prof Mark Loeb (McMaster University, Hamilton, Canada) about his presentation at the American College of Cardiology Annual Meeting 2022. Questions: What is known about the effects of the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!